Top story · July 31, 2026
Mississippi explores ibogaine trials for addiction treatment, reflecting a shift towards health-centered drug policies.
Mississippi advances ibogaine research for addiction treatment, signaling a shift towards health-focused drug policies.
Read the storyJuly 31, 2026
Luttrell's IBOGAINE Act aims to solidify psychedelic therapy access for veterans.
July 30, 2026
The institute seeks approval to study ibogaine's potential in treating addiction.
July 29, 2026
Psychedelic trials often exclude marginalized groups, raising questions about equity and efficacy.
July 29, 2026
State-led ibogaine study in Texas receives federal funding, advancing research into opioid treatment.
July 29, 2026
Ibogaine HCl aims to treat PTSD, TBI, and opioid use disorder.
July 29, 2026
A look at the financials of Universal Ibogaine Inc.
July 29, 2026
State-led ibogaine study in Texas gains federal backing, marking a significant research development.
July 29, 2026
The new program aims to explore ibogaine's potential in treating opioid addiction.
July 29, 2026
Market sentiment for Universal Ibogaine Inc remains under review.
July 28, 2026
Focus on documentation, training, and informed consent
July 28, 2026
YouTube video explores ibogaine's potential in treating disorders.
July 27, 2026
New NDAA provision aims to expand ibogaine access for veterans.
July 25, 2026
Efforts to contain wildfires in France face significant hurdles.
July 25, 2026
TradingView provides a financial overview of Universal Ibogaine Inc.
July 24, 2026
Case report highlights ibogaine's potential in treating severe ketamine use disorder.
July 24, 2026
Internal discussions focus on potential therapeutic uses and regulatory challenges.
July 24, 2026
White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.
July 24, 2026
Rogan's push for ibogaine approval led to conflict with a key Trump aide.
July 24, 2026
Psychoactive drug ibogaine gains attention for addiction treatment potential.
July 24, 2026
Ibogaine research gains momentum under Trump administration's expedited process.
July 24, 2026
The Tijuana-based center marks a milestone in ibogaine treatment for substance use disorder.
July 24, 2026
The Trump administration considers making ibogaine available for therapeutic use.
July 23, 2026
Ibogaine, a psychedelic, eyed for opioid crisis intervention under Trump.
July 23, 2026
Order encourages psychedelic research, allocates $50M for state studies.
July 23, 2026
The amendment aims to expand treatment options for PTSD and addiction.
July 23, 2026
YouTube video explores ibogaine's potential in treating addiction.
July 23, 2026
New provisions in the NDAA aim to enhance veteran care and strengthen global defense partnerships.
July 22, 2026
Proposed NDAA amendment aims to expand treatment options for PTSD and TBI.
July 22, 2026
Trump's 2026 executive order boosts psychedelic research funding and collaboration.
July 21, 2026
Stanford Veterans Study highlights ibogaine's potential for PTSD treatment.
July 21, 2026
Rising mental health challenges could drive biotech innovations.
July 20, 2026
American Bar Association explores legal frameworks for therapeutic safety.
July 19, 2026
Investment interest grows in psychedelics for mental health treatment.
July 17, 2026
Psychedelics like ibogaine may offer lasting brain changes.
July 17, 2026
Pharmaceutical giant expands into psychedelic research with major acquisition.
July 16, 2026
Mayor Gina Ortiz Jones pushes for psychedelic trials to aid veterans.
July 16, 2026
Veterans report transformative effects from psychedelic treatment.
July 16, 2026
Veterans report transformative effects from psychedelic therapy.
July 16, 2026
Ibogaine's role in treating substance use disorders remains controversial.
July 16, 2026
Veterans share recovery stories, highlighting ibogaine's potential.
July 15, 2026
Exhibit explores the evolving role of psychedelics in culture and medicine.
July 15, 2026
New agreement includes ibogaine research for opioid use disorder.
July 15, 2026
Federal support for ibogaine and other psychedelics aims to aid veterans with PTSD.
July 8, 2026
Bipartisan Effort Aims to Reschedule Ibogaine and Expand Therapy Access
July 8, 2026
An Overview of Ibogaine's Journey in the U.S.
July 8, 2026
Ibogaine remains illegal in the U.S., yet clinical trials are underway.
Newsletter
Occasional dispatches on research, policy, and treatment. No spam.